1832P Cardiotoxicity of the HER2 dimerisation inhibitor pertuzumab in patients with breast cancer HER2+: A systematic review

Autor:	C.A. Rodríguez Sánchez, Juan J. Cruz-Hernández, R. Seijas Tamayo, I. Toribio García, R.A. Escala Cornejo, L. Figuero Pérez, J.P. Miramontes González, R. Vidal Tocino, A. Olivares Hernandez, G. Martín García
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty Cardiotoxicity business.industry Hematology medicine.disease Breast cancer Internal medicine medicine In patient Pertuzumab business medicine.drug
Zdroj:	Annals of Oncology. 32:S1240
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.720
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::494deaeb0e33783343efd2690e5eac2a https://doi.org/10.1016/j.annonc.2021.08.720 Zobrazit plný text záznamu